Markets
Markets
AI
Markets
Markets
World
Markets
Novo shares fell as much as 7% on Monday after the company laid out new growth ambitions to revive its fortunes in the booming obesity drug market.
Politics
AI
AI
World
Politics
Markets
AI
Markets
Politics
Markets
Markets
Politics
Markets
Politics
Markets
Markets
World
World
Politics
Politics
Markets
World
World
World
World
Politics
Politics
Politics
Business
Business
Business
Tech
Tech
Tech
Tech
Tech
Tech
Climate
Climate
Climate
AI
AI
AI
Health
Health
Health
World
Politics
AI
Markets
Markets
Markets
AI
Markets
Markets
AI
Politics
AI